Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Lyufei Chen
Turning Spectroscopy Data into an AI Advantage
Artificial intelligence (AI) is rapidly becoming an important tool across pharmaceutical and biopharmaceutical research. Applications ranging from drug discovery and biologics development to formulation screening and quality assessment increasingly rely on machine learning to identify patterns, accelerate decision-making, and improve development efficiency.
Spectroscopic PAT for Real-Time Molecular Fingerprinting
The biopharmaceutical sector is transitioning from reactive off-line quality control to a proactive quality by design (QbD) framework. Process analytical technology (PAT) enables this shift through rapid, non-destructive spectroscopy for continuous monitoring, eliminating analytical delays, and enabling predictive, closed-loop control. Traditional upstream and downstream processes (USP and DSP) rely on slow, episodic measurements that introduce control lag.
Accelerating Biopharma Development: A Greener & Faster Approach with A-TEEM® Spectroscopy for Monoclonal Antibodies and Peptides
Beginning: 12/04/25 Location: Online The biopharmaceutical industry faces increasing pressure to develop therapies faster, more efficiently, and with a smaller environmental footprint. To address these challenges, Process Analytical Technology (PAT) has become indispensable for enabling real-time monitoring, minimizing offline testing, and accelerating development timelines.
Implemention of Innovative Process Analytical Technologies to Characterize Critical Quality Attributes of Co‐Formulated Monoclonal Antibody Products
Conflicts of Interest The authors declare no conflicts of interest. Supporting Information Filename Description bit28881-sup-0001-Supporting_information_Rev.docx22 KB Supporting information. References "Antibody Therapy Market Size, Growth Analysis 2023–2032. (GMI5195)." From Global Market Insights Inc. 2023. "PAT—A Framework for Innovative Pharmaceutical Development, Manufacturing, and Quality Assurance." Rockville, MD: USFDA. 2004. , , , et al. 2011.
Implementation of Innovative Process Analytical Technologies to Characterize Critical Quality Attributes of Co‐Formulated Monoclonal Antibody Products
Conflicts of Interest The authors declare no conflicts of interest. Supporting Information Filename Description bit28881-sup-0001-Supporting_information_Rev.docx22 KB Supporting information. References "Antibody Therapy Market Size, Growth Analysis 2023–2032. (GMI5195)." From Global Market Insights Inc. 2023. "PAT—A Framework for Innovative Pharmaceutical Development, Manufacturing, and Quality Assurance." Rockville, MD: USFDA. 2004. , , , et al. 2011.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Lyufei
Contact Lyufei, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack